M&A Deal Summary

Permira Acquires Cambrex

On August 7, 2019, private equity firm Permira acquired life science company Cambrex for 2.4B USD

Acquisition Highlights
  • This is Permira’s 3rd transaction in the Life Science sector.
  • This is Permira’s 17th largest (disclosed) transaction.
  • This is Permira’s 30th transaction in the United States.
  • This is Permira’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2019-08-07
Target Cambrex
Sector Life Science
Buyer(s) Permira
Deal Type Going Private
Deal Value 2.4B USD
Advisor(s) Morgan Stanley (Financial)
Kirkland & Ellis (Legal)

Target

Cambrex

East Rutherford, New Jersey, United States
Cambrex is a life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapeutics. Cambrex was formed in 1981 and is headquartered in East Rutherford, New Jersey.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Permira

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1985
PE ASSETS 75.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Permira is a mega-sized private equity firm that targets large company investments around the world. Permira invests to support acquisitions, leveraged buyouts, take-privates, turnarounds, and growth buyouts. Areas of interest include healthcare, financial services, chemicals, consumer products and services, industrial products and services, technology, media, and telecom. Permira will consider opportunities in Europe, Asia, and North America. Permira was formed in 1985 and has offices in Menlo Park, Frankfurt, Luxembourg, London, Hong Kong, Madrid, Milan, Paris, Stockholm, Tokyo, Guernsey and New York City.

DEAL STATS #
Overall 129 of 159
Sector (Life Science) 3 of 6
Type (Going Private) 10 of 15
State (New Jersey) 1 of 1
Country (United States) 30 of 44
Year (2019) 4 of 6
Size (of disclosed) 17 of 61
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-18 Quotient Sciences

Nottingham, United Kingdom

Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences is based in Nottingham, England.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-04 Topcast

Hong Kong, China

Topcast connects suppliers with customers in all segments of aviation including airlines, Maintenance, Repair, and Overhaul (MRO) service providers and Original Equipment Manufacturers (OEMs). Topcast operates as an extension of the suppliers offering not only aftermarket support, but also the development of new businesses for its principals. The company also provides technical support and maintenance services and distribution of industrial cables and wires. Topcast was founded in 1991 and is based in Hong Kong.

Buy -
Mergr

Product

Company

Legal